Lancet Infectious Diseases
Journal Abbreviation: LANCET INFECT DIS
ISSN: 1473-3099
eISSN: 1474-4457
Publisher: Elsevier: Lancet
Publications (13)
Adaptive immune responses are larger and functionally preserved in a hypervaccinated individual (2024)
Kocher K, Moosmann C, Drost F, Schülein C, Irrgang P, Steininger P, Zhong J, et al.
Journal article
Neutralisation sensitivity of SARS-CoV-2 lineages EG.5.1 and XBB.2.3 (2023)
Zhang L, Kempf A, Nehlmeier I, Cossmann A, Dopfer-Jablonka A, Stankov MV, Schulz S, et al.
Journal article
Neutralisation sensitivity of the SARS-CoV-2 XBB.1 lineage (2023)
Arora P, Cossmann A, Schulz S, Ramos GM, Stankov MV, Jäck HM, Behrens GM, et al.
Journal article
Omicron sublineage BQ.1.1 resistance to monoclonal antibodies (2023)
Arora P, Kempf A, Nehlmeier I, Schulz S, Jäck HM, Pöhlmann S, Hoffmann M
Journal article
Mycobacterial infections in adults with haematological malignancies and haematopoietic stem cell transplants: guidelines from the 8th European Conference on Infections in Leukaemia (2022)
Bergeron A, Mikulska M, De Greef J, Bondeelle L, Franquet T, Herrmann JL, Lange C, et al.
Journal article, Review article
The effect of cilgavimab and neutralisation by vaccine-induced antibodies in emerging SARS-CoV-2 BA.4 and BA.5 sublineages (2022)
Arora P, Zhang L, Nehlmeier I, Kempf A, Cossmann A, Dopfer-Jablonka A, Schulz SR, et al.
Journal article
Lung cell entry, cell-cell fusion capacity, and neutralisation sensitivity of omicron sublineage BA.2.75 (2022)
Arora P, Nehlmeier I, Kempf A, Cossmann A, Schulz S, Dopfer-Jablonka A, Baier E, et al.
Journal article
Duration of effectiveness of vaccination against COVID-19 caused by the omicron variant (2022)
Arora P, Kempf A, Nehlmeier I, Schulz S, Cossmann A, Stankov MV, Jäck HM, et al.
Journal article, Letter
Augmented neutralisation resistance of emerging omicron subvariants BA.2.12.1, BA.4, and BA.5 (2022)
Arora P, Kempf A, Nehlmeier I, Schulz S, Cossmann A, Stankov MV, Jäck HM, et al.
Journal article
Comparable neutralisation evasion of SARS-CoV-2 omicron subvariants BA.1, BA.2, and BA.3 (2022)
Arora P, Zhang L, Rocha C, Sidarovich A, Kempf A, Schulz S, Cossmann A, et al.
Journal article